Modeling Alzheimer's disease progression utilizing clinical trial and ADNI data to predict longitudinal trajectory of CDR‐SB

Abstract There is strong interest in developing predictive models to better understand individual heterogeneity and disease progression in Alzheimer's disease (AD). We have built upon previous longitudinal AD progression models, using a nonlinear, mixed‐effect modeling approach to predict Clinical D...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Samira Jamalian, Michael Dolton, Pascal Chanu, Vidya Ramakrishnan, Yesenia Franco, Kristin Wildsmith, Paul Manser, Edmond Teng, Jin Y. Jin, Angelica Quartino, Joy C. Hsu, for the Alzheimer's Disease Neuroimaging Initiative
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2023-07-01
Saila:	CPT: Pharmacometrics & Systems Pharmacology
Sarrera elektronikoa:	https://doi.org/10.1002/psp4.12974
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!